WHAT IS THE CLINICAL NEED FOR PREECLAMPSIA (PE) SCREENING? A: PE affects about 2% of pregnancies globally and is a major cause of maternal and perinatal mortality and morbidity. This condition has two major subtypes: early-onset (or preterm) PE, which develops before 34 weeks of gestation, and late...
Read More
For four previously cleared Lyme disease tests, the Food and Drug Administration (FDA) has cleared new indications that may help streamline diagnosis of this condition. The tests are made by Zeus Scientific and include the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM test system, Zeus ELISA Borrelia ...
Read More
AllTest took part in the 2019 edition of the Global Health Exhibition, which was held on Sept. 10-12 at the Riyadh International Convention & Exhibition Center, Saudi Arabia. Over three days, AllTest aimed to build ties and foster cooperation with our existing clients and partners in healthcare ...
Read More
AllTest participated in the ninth edition of Medical Fair Thailand which was held at Queen Sirikit National Convention Center in Bangkok, Thailand from Sep 11-13, 2019. The three-day exhibition coincides with the Mid-Autumn Festival- a blessing to the wind and good luck to the moon. AllTest wishes ...
Read More
Managing a potentially poisoned patient can be difficult and stressful. With the national rise of overdoses in patients using ever-evolving synthetic designer drugs, the current routine drug screening methodologies many laboratories employ may no longer be effective. However, the jumbled maze of ...
Read More
